ISSN: 2329-6631
+44 1478 350008
Robert A Freeman
Professor, Department of Pharmacy Practice & Administration
University of Maryland, USA
Dr. Robert Freeman is currently Professor of Pharmacy Administration (health services research) in the Department of Pharmacy Practice & Administration at the University of Maryland Eastern Shore School of Pharmacy. He has over 20 years’ experience in the global pharmaceutical industry having served as a leader of public policy and health economics functions for AstraZeneca and Sanofi among others. Prior to his current academic position he was Professor of Pharmaceutical Sciences and Director of Graduate Studies at the Rangel College of Pharmacy at Texas A&M Health Sciences Center. He is the author of over 75 research and professional publications in comparative effectiveness research, public policy, health economics & outcomes research and pharmaceutical industry finance economics. His current research focuses on policy initiative to incentivize pharmaceutical R&D. He earned his BS in Pharmacy and his MS and PhD degrees from the University of Mississippi.
His current research focuses on policy initiative to incentivize pharmaceutical R&D.